Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.430
+0.250 (7.86%)
At close: Jun 26, 2026, 4:00 PM EDT
3.420
-0.010 (-0.29%)
After-hours: Jun 26, 2026, 7:08 PM EDT
Prime Medicine Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Prime Medicine stock has a consensus rating of "Buy" and an average price target of $6.92. The average 1-year stock price forecast is 101.75% higher than the current stock price, while the lowest is $4.25 (+23.91%) and the highest is $11 (+220.70%).
Price Target: $6.92 (+101.75%)
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2026.
Analyst Ratings
The average analyst rating for Prime Medicine stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 8 | 8 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +220.70% | May 12, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $5 | Buy | Reiterates | $5 | +45.77% | May 8, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $9 | Buy | Reiterates | $9 | +162.39% | May 8, 2026 |
Unknown Analyst Wedbush No rating | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +133.24% | May 8, 2026 |
Financial Forecast
Revenue This Year
9.45M
from 4.63M
Increased by 104.04%
Revenue Next Year
19.77M
from 9.45M
Increased by 109.15%
EPS This Year
-0.98
from -1.35
EPS Next Year
-0.87
from -0.98
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.2M | ||
| Avg | 9.5M | ||
| Low | 856,000 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,047.6% | ||
| Avg | 104.0% | ||
| Low | -81.5% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.77 | ||
| Avg | -0.98 | ||
| Low | -1.18 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |